Optimal management of breast cancer in the elderly patient: current perspectives

Archive ouverte

Le Saux, O. | Ripamonti, B. | Bruyas, A. | Bonin, O. | Freyer, G. | Bonnefoy, M. | Falandry, Claire

Edité par CCSD ; Dove Medical Press -

International audience. Breast cancer (BC) is the most common female malignancy in the world and almost one third of cases occur after 70 years of age. Optimal management of BC in the elderly is a real challenge and requires a multidisciplinary approach, mainly because the elderly population is heterogeneous. In this review, we describe the various possibilities of treatment for localized or metastatic BC in an aging population. We provide an overview of the comprehensive geriatric assessment, surgery, radiotherapy, and adjuvant therapy for early localized BC and of chemotherapy and targeted therapies for metastatic BC. Finally, we attempt to put into perspective the necessary balance between the expected benefits and risks, especially in the adjuvant setting.

Consulter en ligne

Suggestions

Du même auteur

Inclusion of elderly patients in oncology clinical trials

Archive ouverte | Le Saux, O. | CCSD

International audience. BACKGROUND: Physicians need clinical trials assessing benefits and harms of treatments to avoid under-treatment or over-treatment of elderly patients. The main objectives of this report were ...

Assessing capacity to consent for research in cognitively impaired older patients

Archive ouverte | Gilbert, T. | CCSD

International audience. Background: The number of clinical trials including older patients, and particularly patients with cognitive impairment, is increasing. While statutory provisions exist to make sure that the ...

Le défaut d’expression du transporteur ABCC6 induit le développement de la plaque de Randall et de la lithiase rénale chez l’homme et la souris

Archive ouverte | Letavernier, E. | CCSD

International audience. Le Pseudoxanthome élastique (PXE) est une maladie génétique récessive liée à une mutation du gène ABCC6, exprimé dans le foie et le rein. Cette mutation est à l’origine d’un défaut systémique...

Chargement des enrichissements...